Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPV1 | Q8NER1 | 3/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.45 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.45 |
| ▸ | DHODH | Q02127 | 1/20 | 0.43 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.42 |
| ▸ | FNTA | P49354 | 1/20 | 0.42 |
| ▸ | FNTB | P49356 | 1/20 | 0.42 |
| ▸ | PGGT1B | P53609 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3092862 | 1.00 | TRPV1 (0.58) | TRPV1ALDH1A1ALOX15DHODHNFE2L2 | |
| SCHEMBL15246442 | 0.99 | TRPV1 (0.56) | TRPV1ALDH1A1ALOX15DHODHFNTA | |
| SCHEMBL8058501 | 0.99 | TRPV1 (0.56) | TRPV1ALDH1A1ALOX15DHODHFNTA | |
| SCHEMBL27733182 | 0.99 | TRPV1 (0.56) | TRPV1ALDH1A1ALOX15DHODHFNTA | |
| SCHEMBL8058497 | 0.99 | TRPV1 (0.56) | TRPV1ALDH1A1ALOX15DHODHFNTA | |
| SCHEMBL23802602 | 0.99 | TRPV1 (0.56) | TRPV1ALDH1A1ALOX15DHODHFNTA | |
| SCHEMBL9417659 | 0.88 | TRPV1 (0.50) | TRPV1ALDH1A1DHODHFNTAFNTB | |
| SCHEMBL9417658 | 0.88 | TRPV1 (0.50) | TRPV1ALDH1A1DHODHFNTAFNTB | |
| SCHEMBL21436889 | 0.87 | TRPV1 (0.53) | TRPV1ALDH1A1ALOX15FNTAFNTB | |
| SCHEMBL8712669 | 0.87 | DHODH (0.50) | TRPV1ALDH1A1DHODH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12617747-B2 | Cannabinoid analogs and methods for their preparation | INMED PHARMACEUTICALS INC. (CA) | 2026-05-05 | — | — | US | disclosed |
| US-20240117388-A1 | ACYL ACTIVATING ENZYMES FOR PREPARATION OF CANNABINOIDS | BAYMEDICA, INC. | 2024-04-11 | — | — | US | disclosed |
| EP-4281553-A1 | ACYL ACTIVATING ENZYMES FOR PREPARATION OF CANNABINOIDS | BayMedica, Inc. (US) | 2023-11-29 | — | — | EP | disclosed |
| US-11555211-B2 | Recombinant production systems for prenylated polyketides of the cannabinoid family | BAYMEDICA, INC. (US) | 2023-01-17 | — | — | US | disclosed |
| WO-2022159589-A1 | ACYL ACTIVATING ENZYMES FOR PREPARATION OF CANNABINOIDS | BAYMEDICA, INC. (US) | 2022-07-28 | — | — | WO | disclosed |
| US-20210403408-A1 | CANNABINOID ANALOGS AND METHODS FOR THEIR PREPARATION | INMED PHARMACEUTICALS INC. (CA) | 2021-12-30 | — | — | US | disclosed |
| US-20210403959-A1 | USE OF TYPE I AND TYPE II POLYKETIDE SYNTHASES FOR THE PRODUCTION OF CANNABINOIDS AND CANNABINOID ANALOGS | BAYMEDICA, INC. | 2021-12-30 | — | — | US | disclosed |
| EP-3873451-A1 | CANNABINOID ANALOGS AND METHODS FOR THEIR PREPARATION | BayMedica, Inc. (US) | 2021-09-08 | — | — | EP | disclosed |
| US-20210040512-A1 | RECOMBINANT PRODUCTION SYSTEMS FOR PRENYLATED POLYKETIDES OF THE CANNABINOID FAMILY | BAYMEDICA, INC. | 2021-02-11 | — | — | US | disclosed |
| US-10837031-B2 | Recombinant production systems for prenylated polyketides of the cannabinoid family | BAYMEDICA, INC. (US) | 2020-11-17 | — | — | US | disclosed |
| WO-2020102430-A1 | USE OF TYPE I AND TYPE II POLYKETIDE SYNTHASES FOR THE PRODUCTION OF CANNABINOIDS AND CANNABINOID ANALOGS | BAYMEDICA, INC. (US) | 2020-05-22 | — | — | WO | disclosed |
| EP-3622059-A1 | RECOMBINANT PRODUCTION SYSTEMS FOR PRENYLATED POLYKETIDES OF THE CANNABINOID FAMILY | BayMedica, Inc. (US) | 2020-03-18 | — | — | EP | disclosed |
| CN-110869496-A | Recombinant production system for pentenylated polyketones of the cannabinoid family | 海湾医学公司 | 2020-03-06 | — | — | CN | disclosed |
| US-20180334692-A1 | RECOMBINANT PRODUCTION SYSTEMS FOR PRENYLATED POLYKETIDES OF THE CANNABINOID FAMILY | BAYMEDICA, INC. | 2018-11-22 | — | — | US | disclosed |
| WO-2018209143-A1 | RECOMBINANT PRODUCTION SYSTEMS FOR PRENYLATED POLYKETIDES OF THE CANNABINOID FAMILY | BAYMEDICA, INC. (US) | 2018-11-15 | — | — | WO | disclosed |
| EP-0711749-B1 | Process for producing geranylgeraniol | KURARAY CO (JP) | 1998-05-20 | — | — | EP | disclosed |
| US-5663461-A | HYDROLYSIS OF ESTER | KURARAY CO., LTD. (JP) | 1997-09-02 | — | — | US | disclosed |
| EP-0711749-A1 | Process for producing geranylgeraniol | KURARAY CO., LTD. (JP) | 1996-05-15 | — | — | EP | disclosed |
| US-4514573-A | ANTIVIRAL | NISSHIN FLOUR MILLING CO., LTD. (JP) | 1985-04-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12617747-B2 | Cannabinoid analogs and methods for their preparation | CNR2, CNR1, FAAH | TRPV1 119/4885ALDH1A1 1831/4885ALOX15 1446/4885 |
| US-20210403408-A1 | CANNABINOID ANALOGS AND METHODS FOR THEIR PREPARATION | CNR1, CNR2, ERG28 | TRPV1 591/4885ALDH1A1 4218/4885ALOX15 1832/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.